Tracking trends in HIV/AIDS mortality pre- & post ART: South Africa

Slides:



Advertisements
Similar presentations
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Questionnaire for Children Under Five: Malaria.
Advertisements

No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
South African National HIV Prevalence, Incidence and Behaviour Survey, 2012 Presenter: Prof LC Simbayi Executive Director, HAST Programme, Human Sciences.
Modelling HIV/AIDS in Southern Africa Centre for Actuarial Research (CARe) A Research Unit of the University of Cape Town.
HIV AND AGING Carol Nawina NYIRENDA PAN AFRICAN POSITIVE WOMENS COALITION (PAPWC) COALITION OF ZAMBIAN WOMEN LIVING WITH HIV.
HIV/AIDS Major effects on women and children in developing countries.
UNAIDS, Regional Support Team, Eastern and Southern Africa
HIV Mortality in Florida 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Death data.
Measuring Burden of Disease - an essential foundation to improve health Prof Debbie Bradshaw Dr Pam Groenewald MRC Burden of Disease Research Unit David.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Implementing antiretroviral therapy rollout to strengthen the health care system Dr Olive Shisana Human sciences Research Council.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
GAP Report 2014 People left behind: People aged 50 years and older Link with the pdf, People aged 50 years and older.
LESOTHO CASE STUDY. GENERAL STATS Landlocked country surrounded by South Africa Population : million Life expectancy : year Second highest.
Edward Mills PhD, Associate Professor, Faculty of Health Sciences University of Ottawa AIDS Mortality Among Men in Africa: An overview of the evidence.
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
POPULATION & MIGRATION AP HuG Unit 2 (Chapters 2 & 3)
Salim S. Abdool Karim, MBChB, PhD and Quarraisha Abdool Karim, PhD.
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
Projected Population and HIV/AIDS Update 18 May 2011 National Health Insurance Policy Brief 18.
THE VITAL NEED FOR DEATH REGISTRATION – LESSONS FROM SOUTH AFRICA Pam Groenewald and Debbie Bradshaw SAMRC BURDEN OF DISEASE RESEARCH UNIT 21 ST INTERNATIONAL.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Child Health.
MODERN AFRICA (21st Century)
Trends in maternal deaths in HIV-infected women, on a background of changing HIV management guidelines in South Africa: 1997 to ,2,3CN Mnyani, 1EJ.
Contents - HIV global slides
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Overview of Global HIV Epidemic
Opportunities and prospects.
27 years of responding to AIDS
Reducing global mortality of children and newborns
Global summary of the AIDS epidemic, 2008
Trade Union Training on the Validation of the training manual entitled “Union Training on Occupational Safety and Health” HEALTH & HIV/AIDS.
Lung cancer prevalence on the rise (Nov. 2014)
Global summary of the AIDS epidemic, 2008
27 years of responding to AIDS
25 years of AIDS People living with HIV Children orphaned by AIDS in
World Health Organization
MILLENIUMS DEVELOPMENT GOALS
From Knowledge to action
MODERN (21st Century) Africa
WHO HIV update July 2018 Global epidemic Global progress and cascade
AIDS Acquired Immunodeficiency Syndrome (AIDS) is a disease that is spread through blood and other bodily fluids. It attacks and destroys the immune system,
AIDS Acquired Immunodeficiency Syndrome (AIDS) is a disease that is spread through blood and other bodily fluids. It attacks and destroys the immune system,
27 years of responding to AIDS
Finding the right target population for PrEP The cost-effectiveness of PrEP provision to adolescents and young women in South Africa Gesine Meyer-Rath1,2,
Contents - HIV global slides
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Showing throughout the event
Update on HIV and TB situation in SEAR Dr Mukta Sharma RA HIV TB HEP WHO SEARO Global Fund , South-East Asia Constituency Meeting, April 2018,
Estimated number of people living with HIV and adult HIV prevalence
AIDS Trends   For all slides in this series, the following notes apply:
AIDS-related deaths the lowest this century
Contents - HIV global slides
“The more there are suffering, then the more natural their sufferings appear. Who wants to prevent the fish in the sea from getting wet? Bertolt Brecht.
Global summary of the HIV and AIDS epidemic, 2005
Volume 382, Issue 9893, Pages (August 2013)
Lorna Perez, Ethan Gough
Collaborative TB/HIV activities in European Region
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Contents - HIV global slides
FORECASTING THE IMPACT OF HIV/AIDS NATIONALLY AND IN SUB-POPULATIONS
GBD 2016 estimates problematic for South Africa
Contents Global impact 2.Service cascade 3. Policies and WHO support.
AIDS Acquired Immunodeficiency Syndrome (AIDS) is a disease that is spread through blood and other bodily fluids. It attacks and destroys the immune system,
Trends in the HIV incidence rate following ART scale-up in a rural and hyper-endemic South Africa population (2004–2015) Alain Vandormael, PhD School of.
Global summary of the HIV and AIDS epidemic, 2005
The Medical Research Council
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Public Health Implications
Presentation transcript:

Tracking trends in HIV/AIDS mortality pre- & post ART: South Africa 1997-2012 Pillay-van Wyk V1, Bradshaw D1, Msemburi W1, Dorrington RE2, Laubscher R3, Groenewald P1 1Burden of Disease Research Unit, South African Medical Research Council, Cape Town 2Centre for Actuarial Research, University of Cape Town 3Biostatistics Unit, South African Medical Research Council, Cape Town Good afternoon, today I am going to share with you HIV/AIDS mortality trends or South Africa pre and post the antiretroviral treatment roll out using data from the second national burden of disease study.

BACKGROUND & METHODS South Africa extensive anti-retroviral (ART) rollout in sub-Saharan Africa ART programme began in 2005 Trends in HIV/AIDS mortality pre-&-post ART rollout 2nd South African National Burden of Disease study Vital registration data adjusted for mis-attributed HIV/AIDS deaths other data deficiencies South Africa has one of the most extensive ART programs in Sub Saharan Africa and this program was rolled out in 2005. Our country has a vital registration system that routinely collects cause of death information. However due to the stigma around HIV/AIDS in the country doctors don’t certify HIV/AIDS as a cause of death but rather attribute the death to AIDS indicator causes like TB, Diarrhoeas, Pneumonia – we identified 19 such causes – and removed the HIV/AIDS death from them and reallocated these deaths to HIV/AIDS. We also adjusted for other data deficiencies.

METHODS: Estimated HIV/AIDS deaths by reported cause of death and age, 1997- 2012 (N=~3,189,000 deaths) So after adjusting for misclassified HIV/AIDS deaths we found over 3 million deaths for the study period. This graph shows the number of AIDS deaths by age group that was reported to an AIDS indicator cause. Note the brown line at the bottom refers to the number of reported HIV/AIDS deaths in the vital registration data. The bars above represent the AIDS deaths that were re-attributed to HIV/AIDS and the AID indicator conditions they were taken from for example TB – the dark blue bar and diarrhea the dark green bar

RESULTS HIV/AIDS was the leading cause of death Number of HIV/AIDS deaths in 1997: 60 336 (14.5%) 2006: 283 564 (41.9%) 2012: 153 661 (29.1%) HIV/AIDS mortality rates peaked for females in 2005 and males in 2006 HIV/AIDS was the leading cause of death through out the study period accounting of 14% of totals in 1997, 41% by 2006 and 29% by 2012. HIV/AIDS Mortality peaked in 2006 for males and 2005 for women. 2nd SOUTH AFRICAN NATIONAL BURDEN OF DISEASE STUDY

RESULTS: HIV/AIDS death rates by sex & age group for 1997, 2000, 2006 & 2012 This graph reports the HIV/AIDS deaths rates for males on the left and females on the right by age group. In the 25-34 years age group, females had higher death rates than males. This pattern was reversed in the 45 years and older with males having higher rates. Males death rates among the 65 years and older age group was at the same level in 2012 as 2006, while death rates for males in the other ages declined after 2006. This shows little difference in mortality rates by age group for males over the age of 45 years. Female mortality rates had reached similar levels as 2000 by 2012.

CONCLUSION HIV/AIDS is the leading cause of death even though the number of HIV/AIDS deaths have almost halved since the ART roll out High HIV/AIDS mortality rates in males older than 45 years old by 2012 Treatment and prevention programmes should strategies how to target this risk group In conclusion, the number of deaths from HIV/AIDS have almost halved since the ART rollout showing that we have made gains in the fight against the HIV/AIDS epidemic in South Africa. However HIV/AIDS is still the leading cause of death in South. And males older than 45 years of age still have high mortality rates and have been identified as a risk group. Therefore we recommend that treatment and prevention programmes include in their stragetises how to target this risk group.

SOUTH AFRICAN BURDEN OF DISEASE TEAM Medical Research Council Dr Victoria Pillay-van Wyk Dr Debbie Bradshaw Mr William Msemburi Ms Ria Laubscher Dr Pam Groenewald Dr Richard Matzopolous Ms Megan Prinsloo Ms Beatrice Nojilana Dr Nadine Nannan Ms Nomonde Gwebushe Ms Ntuthu Somdyala Ms Nomfuneko Sithole Medical Research Council (cont) Mr Ian Neethling Dr Edward Nicol Dr Anastasia Rossouw Dr Jané Joubert University of Cape Town Prof Rob Dorrington Institute of Health Metrics Evaluation Prof Theo Vos FUNDERS